Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

The Brain in Lupus

Michael Lockshin, MD, and Liza Kozora, PhD  |  

The Mary Kirkland Center lupus conference offers insight into cognitive aspects of SLE

Reading Rheum

Kathleen A. Haines, MD  |  

Handpicked Reviews of Contemporary Literature

Antiphospholipid Syndrome

  |  

Antiphospholipid syndrome (APS) is an autoimmune disease associated with frequent clotting in arteries and veins and fetal losses. The clotting results from the presence of proteins in the blood—called antiphospholipid autoantibodies (aPL)—formed against the person’s own tissues.

Key Grassroots Opportunity

  |  

Congress is in recess August 11 through September 5. During this time, members of Congress are meeting with constituents in their district offices, so this is a great opportunity for you to…

Why the REF?

Leslie Crofford, MD  |  

I am delighted to use the occasion of this inaugural REF president’s column to share a vision of the future and describe the exciting developments that will allow us to meet the challenges ahead. Although most of you know that the ACR is associated with a foundation, I find that many of our members wonder what the REF does that is different from the mission and activities of the ACR and the ARHP. In the simplest terms, the ACR and the ARHP are engaged in improving the quality of our professional lives as rheumatologists and rheumatology health professionals, while the core mission of the REF is to ensure the future of our specialty.